Unfavorable efficacy of pembrolizumab for advanced extramammary Paget's disease with high tumor mutation burden after failure of taxane‐based regimens

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Journal of dermatology 2024-06, Vol.51 (6), p.e203-e204
Hauptverfasser:	Koizumi, Shigeru, Doi, Reiichi, Aitake, Urara, Lei, Xiaofeng, Izumi, Teruaki, Mori, Tatsuhiko, Shojiguchi, Naoko, Kawasaki, Tomonori, Inozume, Takashi, Kishi, Akiko
Format:	Artikel
Sprache:	eng
Schlagworte:	Aged Antibodies, Monoclonal, Humanized - administration & dosage Antibodies, Monoclonal, Humanized - therapeutic use Antineoplastic Agents, Immunological - therapeutic use Antineoplastic Combined Chemotherapy Protocols - therapeutic use Female Humans Male Mutation Paget Disease, Extramammary - diagnosis Paget Disease, Extramammary - drug therapy Paget Disease, Extramammary - genetics Paget Disease, Extramammary - pathology Paget's disease Pembrolizumab Skin Neoplasms - drug therapy Skin Neoplasms - genetics Skin Neoplasms - pathology Taxoids - administration & dosage Taxoids - therapeutic use Treatment Failure
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!